Pharmacotherapy in Obesity

Pharmacologic Treatment of Overweight and Obesity in Adults - NCBI

Six anti-obesity medications (AOMs) are approved by the Federal Drug Administration (FDA) for the long-term treatment of obesity.

an update on the available medications and drugs under investigation

Phentermine combined with topiramate is approved for long term treatment of obesity. Topiramate is a gamma-aminobutyric acid agonist, glutamate ...

Pharmacologic Therapy for Obesity - StatPearls - NCBI Bookshelf

This activity will cover updates on recent advancements in pharmacologic therapies, focusing on their efficacy not only in weight loss but also in managing ...

Pharmacotherapy for obesity: moving towards efficacy improvement

In this review, we focus on the currently available anti-obesity medications, discuss the results of semaglutide, and present perspectives on the future of ...

Obesity in adults: Drug therapy - UpToDate

Outline · Tirzepatide · - Dosing and monitoring · - Efficacy for weight loss · - Adverse effects and contraindications · Subcutaneous semaglutide 2.4 mg · - ...

Pharmacotherapy for adults with overweight and obesity - The Lancet

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

Anti-obesity drug discovery: advances and challenges - Nature

Here, we provide an overview of the history of AOM development, focusing on lessons learned and ongoing obstacles.

Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond ...

The purpose of this Expert Endocrine Consult is to introduce an updated approach to the medical treatment of obesity considering recent advances in the field ...

Pharmacotherapy for obesity: What you need to know

This article reviews current drug therapy for obesity, including dosages, approved duration of use, mechanisms of action, adverse effects, potential ...

Pharmacotherapy for Obesity | JN Learning

Five drugs are now approved by the US FDA for long-term weight management in adults: orlistat, phentermine/topiramate, naltrexone/bupropion ...

Current pharmacotherapy for obesity | Nature Reviews Endocrinology

As not all individuals with obesity respond to lifestyle modification, pharmacotherapy has a key role in tackling the obesity epidemic.

Pharmacotherapy of obesity: Available medications and drugs under ...

In this review, evidence on the food and drug administration (FDA)-approved medications, ie, orlistat, lorcaserin, phentermine/topiramate, liraglutide and ...

Pharmacotherapy in Obesity Management

Obesity medications are effective for managing weight and weight-related health issues, often in combination with healthy behaviour changes and/or ...

Progress in Pharmacotherapy for Obesity - JAMA Network

Only 3% of adults trying to lose weight reported taking prescription antiobesity medications between 2012 and 2016.

Pharmacotherapy for obesity - Li - 2009 - British Journal of Clinical ...

Obesity is associated with increased risk of conditions such as hypertension, dyslipidaemia, diabetes mellitus, and obstructive sleep apnoea ...

Pharmacotherapy for obesity - RACGP

Pharmacotherapy can be a useful adjunct to lifestyle intervention in effecting and maintaining clinically meaningful weight loss.

Pharmacotherapy in Obesity: Not Just for Three Months

Effective pharmacotherapy for obesity is currently available and should be considered lifelong. Similar therapies are frequently used in individuals with ...

Pharmacotherapy for Obesity | Rethink Obesity®

Pharmacotherapy can play an important role in weight management by supplementing healthy eating and physical activity.

Pediatric Obesity Pharmacotherapy: State of the Science, Research ...

The evidence review underlying the CPG concluded before the publication of clinical trials of new pharmacotherapy options; thus, the ...

Pharmacotherapy of Obesity: Limits and Perspectives - SpringerLink

This review describes the pharmacotherapy currently available in the USA, Europe, and Brazil, focusing on its limitations.